EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antibacterial activity and mechanism of luteolin isolated from Lophatherum gracile Brongn. against multidrug-resistant Escherichia coli

Yahao Ding, Guilan Wen, Xingke Wei, Hao Zhou, Chunjie Li, Zhengqin Luo, Deyuan Ou, Jian Yang, Xuqin Song

Frontiers in Pharmacology · 24.06.2024 · 15

DOI: 10.3389/fphar.2024.1430564 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 24.06.2024. Verfasst von Yahao Ding und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Animal Genetics, Breeding and Reproduction in the Plateau Mountainous Region, Ministry of Education, Guizhou University, Guiyang, China. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infections caused by multidrug-resistant (MDR) bacteria have become a major challenge for global healthcare systems. The search for antibacterial compounds from plants has received increasing attention in the fight against MDR bacteria. As a medicinal and edible plant, Lophatherum gracile Brongn. ( L. gracile ) has favorable antibacterial effect. However, the main antibacterial active compound and its antimicrobial mechanism are not clear. Here, our study first identified the key active compound from L. gracile as luteolin. Meanwhile, the antibacterial effect of luteolin was detected by using the broth microdilution method and time-kill curve analysis. Luteolin can also cause morphological structure degeneration and content leakage, cell wall/membrane damage, ATP synthesis reduction, and downregulation of mRNA expression levels of sulfonamide and quinolones resistance genes in multidrug-resistant Escherichia coli (MDR E. coli ). Furthermore, untargeted UPLC/Q-TOF-MS-based metabolomics analysis of the bacterial metabolites revealed that luteolin significantly changed riboflavin energy metabolism, bacterial chemotaxis cell process and glycerophospholipid metabolism of MDR E. coli . This study suggests that luteolin could be a potential new food additive or preservative for controlling MDR E. coli infection and spread.

Schlagwörter

Stichwörter der Autor:innen

Lophatherum gracile Brongn.antibacterial mechanismluteolinmultidrug-resistant Escherichia coliuntargeted metabolomics

Autor:innen und Institutionen

  • Laboratory of Animal Genetics, Breeding and Reproduction in the Plateau Mountainous Region, Ministry of Education, Guizhou University, Guiyang, China.
  • College of Animal Science, Guizhou University, Guiyang, China.
  • Pearl River Fisheries Research Institute, Chinese Academy of Fishery Sciences, Guangzhou, China.
  • Laboratory of Pulmonary Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, Sichuan University, Chengdu, China.

Zitieren

APA

Ding, Y., Wen, G., Wei, X., Zhou, H., Li, C., Luo, Z., Ou, D., Yang, J., & Song, X. (2024). Antibacterial activity and mechanism of luteolin isolated from Lophatherum gracile Brongn. against multidrug-resistant Escherichia coli. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1430564

Vancouver

Ding Y, Wen G, Wei X, Zhou H, Li C, Luo Z, et al. Antibacterial activity and mechanism of luteolin isolated from Lophatherum gracile Brongn. against multidrug-resistant Escherichia coli. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1430564

BibTeX
@article{Ding2024,
  author = {Ding, Yahao and Wen, Guilan and Wei, Xingke and Zhou, Hao and Li, Chunjie and Luo, Zhengqin and Ou, Deyuan and Yang, Jian and Song, Xuqin},
  title = {Antibacterial activity and mechanism of luteolin isolated from Lophatherum gracile Brongn. against multidrug-resistant Escherichia coli},
  journal = {Frontiers in Pharmacology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fphar.2024.1430564}
}
Kostenlos starten →